|
[18F]-FEOBV Radiotracer Clinical Trials
1 actively recruiting trial across 1 location
Also known as: [18F]-fluoroethoxybenzovesamicol
Pipeline
Phase 2: 1
Top Sponsors
- Vanderbilt University Medical Center1
Indications
- Down Syndrome, Partial Trisomy 211
- Alzheimer's Disease1
- Down Syndrome1
- Alzheimer Disease1
Nashville, Tennessee1 trial
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
Vanderbilt University Medical Center Clinical Research Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.